With recent research into incretinbased therapies, particularly glucagonlike peptide1 receptor agonists (GLP1s), clinicians are asking whether these drugs can improve outcomes in PAD patients treated with GLP1s, beyond Read More GLP1s for PAD: Using Incretins to Protect Limbs as Well as Hearts Peripheral artery disease (PAD) affects millions of people with type 2 diabetes worldwide, increasing the risk of cardiovascular events and limb loss
Specific Peptides and Their Benefits BPC-157 Delivery Method: Injection, nasal spray, oral spray, capsules, IV administration Benefits: Promotes healing of muscles, tendons, and ligaments
10.1016/j.jns.2013.11.028 154
Shed been on Mounjaro (tirzepatide) for diabetes and was doing great with weight loss as a side effect
Theyre generally pretty effective at reducing your symptoms, but they do come with some side effects